Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Sanofi S.A. buy gerihouse

Sanofi S.A.
Start price
€73.93
11.09.13 / 50%
Target price
€95.00
31.10.13
Performance (%)
6.25%
End price
€78.55
31.10.13
Summary
This prediction ended on 31.10.13 with a price of €78.55. With a performance of 6.25%, the BUY prediction by gerihouse for Sanofi S.A. closed with a slight gain. gerihouse has a follow-up prediction for Sanofi S.A. where he still thinks Sanofi S.A. is a Buy. gerihouse has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Sanofi S.A. 6.062% 6.062% -10.110% 6.691%
iShares Core DAX® 2.594% -1.158% 14.782% 16.813%
iShares Nasdaq 100 3.553% -1.727% 43.265% 44.227%
iShares Nikkei 225® 0.687% -8.354% 18.454% 1.361%
iShares S&P 500 2.209% -0.942% 31.361% 42.812%

According to gerihouse what are the pros and cons of Sanofi S.A. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Cons

Comments by gerihouse for this prediction

In the thread Sanofi S.A. diskutieren
Prediction Buy
Perf. (%) 6.25%
Target price 95.000
Change
Ends at 31.10.13

Attraktiv

Nach letzten Kursrücksetzer wieder attraktiv.

Die Deutsche Bank hat die Einstufung für Sanofi auf "Buy" mit einem Kursziel von 95 Euro belassen. Zuletzt hätten mögliche Pläne des Konsumgüterherstellers L'Oreal verunsichert, seine Sanofi-Beteiligung zu verkaufen, schrieb Analyst Mark Clark in einer Studie vom Dienstag. Die negative Kursreaktion bei Sanofi deute auf Sorgen am Markt wegen eines Aktienüberhangs hin. Allerdings sehe er keinen Grund, warum der Pharmakonzern den von L'Oreal gehaltenen Anteil nicht komplett zurückkaufen sollte. Dies wäre strategisch sinnvoll. Die Verschuldung von Sanofi liege unter der selbst gesetzten Grenze und das Unternehmen selbst habe mehrfach das Fehlen wertschöpfender Übernahmeoptionen beklagt.

gerihouse 
0
Report Share
11.09.13
Prediction Buy
Perf. (%) 6.25%
Target price 95.000
Change
Ends at 31.10.13

(Vom Mitglied beendet)

gerihouse 
0
Report Share
31.10.13

Current prediction by gerihouse for Sanofi S.A.

buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€89.45
19.12.23
€99.00
19.12.24
2.68%
26.04.24

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
gerihouse 
19.12.23 50%

Stopped prediction by gerihouse for Sanofi S.A.

buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€79.36
11.08.22
€110.00
11.08.23
22.37%
12.08.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
gerihouse 
11.08.22 70%
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€86.85
08.07.21
€115.00
08.07.22
13.32%
08.07.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
gerihouse 
08.07.21 80%
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€78.91
02.04.20
€100.00
18.06.20
16.50%
18.06.20

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
gerihouse 
02.04.20 50%
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€77.96
15.12.15
€89.00
21.04.16
-0.09%
21.04.16

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
gerihouse 
02.08.19 50%
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€71.51
28.02.13
€92.00
08.03.13
6.14%
08.03.13

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
gerihouse 
02.08.19 50%